WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H109523
CAS#: 33627-41-7
Description: Natural inhibitor of the hyperplasia of neointima by modulating the balance of MMP-2 and TIMP-2.
Hodoodo Cat#: H109523
Name: Inulicin
CAS#: 33627-41-7
Chemical Formula: C17H24O5
Exact Mass: 308.16
Molecular Weight: 308.370
Elemental Analysis: C, 66.21; H, 7.85; O, 25.94
Synonym:
IUPAC/Chemical Name: 3-[(3aS,4R,5R,8aR)-4-Hydroxy-5,7-dimethyl-3-methylidene-2-oxo-4,5,8,8a-tetrahydro-3aH-cyclohepta[b]furan-6-yl]propyl acetate
InChi Key: QKVABRCMWRXFAF-HMTTWLPMSA-N
InChi Code: InChI=1S/C17H24O5/c1-9-8-14-15(11(3)17(20)22-14)16(19)10(2)13(9)6-5-7-21-12(4)18/h10,14-16,19H,3,5-8H2,1-2,4H3/t10-,14-,15-,16-/m1/s1
SMILES Code: CC(OCCCC1=C(C)C[C@@]([C@@]([C@H](O)[C@@H]1C)([H])C2=C)([H])OC2=O)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 308.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Li JJ, Wen JK, Han M. [Inulicin inhibits activation and expression of vascular remodeling enzymes induced by de-endothelium]. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2008 May;24(2):156-60. Chinese. PubMed PMID: 21141515.
2: Zhao J, Wen J, Han M. [Determination of acetylbritannilactone in inulicin and rat plasma by micellar electrokinetic capillary chromatography with on-line sweeping concentration technique]. Se Pu. 2006 Sep;24(5):508-12. Chinese. PubMed PMID: 17165550.
3: Belova LF, Baginskaia AI, Trumpe TE, Sokolov SIa, Rybalko KS. [Pharmacological properties of inulicin, a sesquiterpene lactone from Japanese inula]. Farmakol Toksikol. 1981 Jul-Aug;44(4):463-7. Russian. PubMed PMID: 7286207.